Perez, Leslie External Author

Publications

Sort by

Selected publications

  • A Phase 1/2 Trial of Ruxolitinib and Erlotinib in Patients with EGFR-Mutant Lung Adenocarcinomas with Acquired Resistance to ErlotinibJournal of Thoracic Oncology2017 Academic Article GET IT
    Times cited: 4